Analysts think IONS stock price could increase by 89%
Mar 14, 2025, 11:25 AM
-15.26%
What does IONS do
Ionis Pharmaceuticals, headquartered in Carlsbad, California, develops drugs using antisense technology and has five marketed medicines, including SPINRAZA and QALSODY, with a pipeline focused on neurology and cardiology. The company employs 927 people and has nine medicines in Phase III development.
25 analysts think IONS stock price will increase by 88.95%. The current median analyst target is $62.22 compared to a current stock price of $32.93. The lowest analysts target is $37.37 and the highest analyst target is $81.90.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
